Key barriers in adhering to anticoagulation guidelines included uncertainty about its choice, established practices, and the ...

Treatments can be prescribed to reduce your risk of complications that can lead to death. Pulmonary embolism (PE) is a potentially life-threatening condition with variable effects on life expectancy.

In pulmonary embolism, systemic anticoagulation is the cornerstone treatment. Unless a specific contraindication exists, professional guidelines recommend LMWH and DOACs over UFH for the majority ...

A pulmonary embolism is the most common pathology of a pulmonary angiogram. Options for treatment of a pulmonary embolism include: Pulmonary angiography of the lungs involves tests that examine ...

Traveling often includes sitting for periods of time, which can increase your chances of developing a deep vein thrombosis, a type of blood clot that forms in a large vein. Part of the clot can break ...

In the era of DOACs, risk for CTEPH following pulmonary embolism is affected by multiple factors, including gender and heart load.

A recent review of the programme showed that 0.3% of almost 12,000 CT scans were positive for pulmonary embolism. The wait time for these patients to get a diagnosis and start a treatment plan was ...

With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...

Moderator Suresh Vedantham, MD, asks Leslie Lake, Volunteer President of the National Blood Clot Alliance and bilateral PE ...

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...